Clinical Trials

Find trials
Search tips
Perform a New Search

Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5301-5310 of 11668

Edit search filters

  1. Study And Safety Monitoring Of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed The Phase II Study AG10-201

    Rochester, MN

  2. A Study To Test Nivolumab With Usual Chemotherapy Treatment Or Usual Chemotherapy Treatment Alone To Treat Recurrent Or Metastatic Nasopharyngeal Cancer

    Jacksonville, FL, Rochester, MN

  3. A Study Of Momelotinib Versus Danazol In Symptomatic And Anemic Myelofibrosis Patients

    Scottsdale/Phoenix, AZ

  4. A Study To Evaluate Proton Therapy To Treat Low-Grade Glioma

    Rochester, MN

  5. A Study To Evaluate ION251 To Treat Patients With Relapsed/Refractory Multiple Myleoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Compare The Effectiveness, Safety And Tolerability Of P1101 Vs. Anagrelide For Essential Thrombocythemia

    Scottsdale/Phoenix, AZ

  7. A Study To Evaluate The Efficacy And Safety Of CLBS16 In Subjects With Coronary Microvascular Dysfunction And Without Obstructive Coronary Artery Disease

    Rochester, MN

  8. A Study To Determine If Identification Of Undiagnosed Atrial Fibrillation In People At Least 70 Years Of Age Reduces The Risk Of Stroke

    Jacksonville, FL

  9. A Study To Evaluate The Safety And Effectiveness Of APT-1011 To Treat Eosinophilic Esophagitis

    Rochester, MN

  10. A Study Of Patidegib Topical Gel, 2%, For The Reduction Of Disease Burden Of Persistently Developing Basal Cell Carcinomas (BCCs) In Subjects With Basal Cell Nevus Syndrome

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer